Leadership

John Prufeta

John Prufeta

Board Observer

John Prufeta is General Partner of Medical Excellence Capital, LLC, a life sciences venture capital firm focused on Gene and Cell Therapy, Quantum Biology, and Regenerative Medicine. He serves as a Director of several MEC portfolio companies, including ProJenX, which is developing treatments for ALS, and TwoStep Therapeutics, which is developing multi-specific targeted therapies for solid tumors. He also serves as a board observer of Avilar Therapeutics.

Mr. Prufeta is Chair of The Medical Excellence Foundation, a 501(c)(3) organization that funds cutting-edge medical research at leading U.S. research institutions. In 2007, he founded Medical Excellence International (MEI), a global private health advisory firm, where he continues to serve as Chair.

Mr. Prufeta is the former President and CEO of Medix Resources, a publicly held (NYSE: MXR) health care technology company. His prior experience includes serving as Managing Partner of Agilence Health Advisors and OnPoint Partners.

His charitable and advisory roles include Director of Business Executives for National Security; founding Board member and Vice Chair of Veterans Moving Forward, an organization serving disabled veterans; President’s Advisory Board Member of Cold Spring Harbor Laboratory; and Advisor to the Center for BioTechnology at Stony Brook University. He has served as an expert and provided testimony to the United States Senate regarding U.S. biotech competitiveness.

He is a graduate of St. John’s University and Harvard Business School.

❮ Back to Leadership